Abstract
Background: For the first time in December 2019, as reported in the Wuhan city of China, COVID-19 deadly virus spread rapidly around the world and the first cases were seen in Turkey on March 11, 2020. On the same day, a pandemic was declared by the World Health Organization due to the rapid spread of the disease throughout the world.
Methods: In this study, a multilayered perception feed-forward back propagation neural network has been designed for predicting the spread and mortality rate of the COVID-19 virus in Turkey. COVID-19 data from six different countries were used in the design of the artificial neural network, which has 15 neurons in its hidden layer. 70% of these optimized data were used for training, 20% for validation, and 10% for testing.
Results: The simulation results showed that the COVID-19 virus in Turkey, between day 20 and 37, was the fastest to rise. The number of cases for the 20th day was predicted to be 13.845.
Conclusion: As for the death rate, it was predicted that a rapid rise would start on the 20th day and a slowdown around the 43rd day and progress towards the zero case point. The death rate for the 20th day was predicted to be 170 and for the 43rd day it was 1,960s.
Keywords: CoVID-19, Turkey, Wuhan, artificial neural network, viral transmission, pandemic, SARS-CO-V-2.
Coronaviruses
Title:Prediction of Infection and Death Ratio of COVID-19 Virus in Turkey by Using Artificial Neural Network (ANN)
Volume: 2 Issue: 1
Author(s): Andaç Batur Çolak*
Affiliation:
- Department of Mechanical Engineering, Nigde Omer Halisdemir University, Nigde 51240,Turkey
Keywords: CoVID-19, Turkey, Wuhan, artificial neural network, viral transmission, pandemic, SARS-CO-V-2.
Abstract:
Background: For the first time in December 2019, as reported in the Wuhan city of China, COVID-19 deadly virus spread rapidly around the world and the first cases were seen in Turkey on March 11, 2020. On the same day, a pandemic was declared by the World Health Organization due to the rapid spread of the disease throughout the world.
Methods: In this study, a multilayered perception feed-forward back propagation neural network has been designed for predicting the spread and mortality rate of the COVID-19 virus in Turkey. COVID-19 data from six different countries were used in the design of the artificial neural network, which has 15 neurons in its hidden layer. 70% of these optimized data were used for training, 20% for validation, and 10% for testing.
Results: The simulation results showed that the COVID-19 virus in Turkey, between day 20 and 37, was the fastest to rise. The number of cases for the 20th day was predicted to be 13.845.
Conclusion: As for the death rate, it was predicted that a rapid rise would start on the 20th day and a slowdown around the 43rd day and progress towards the zero case point. The death rate for the 20th day was predicted to be 170 and for the 43rd day it was 1,960s.
Export Options
About this article
Cite this article as:
Çolak Batur Andaç*, Prediction of Infection and Death Ratio of COVID-19 Virus in Turkey by Using Artificial Neural Network (ANN), Coronaviruses 2021; 2(1) . https://dx.doi.org/10.2174/2666796701999200915142539
DOI https://dx.doi.org/10.2174/2666796701999200915142539 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Association of Viruses in the Development of Cardiovascular Diseases
Current Pharmaceutical Design Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies
Mini-Reviews in Medicinal Chemistry Coronavirus (COVID-19) and Employee Health
Coronaviruses Targeting Infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) Applications: Evidence Based Opinion
Infectious Disorders - Drug Targets Recent Developments on Coronavirus Main Protease/3C Like Protease Inhibitors
Recent Patents on Anti-Infective Drug Discovery Recent Patents and Advances on Nanotechnologies against Coronavirus
Recent Patents on Nanotechnology A Mini-review of Computational Approaches to Predict Functions and Findings of Novel Micro Peptides
Current Bioinformatics Survival Analysis Based on the Siddha Body Constitution of Asymptomatic SARS-CoV-2 Patients Under Integrative Management of Hydroxychloroquine (HCQ) and Kaba Sura Kudineer (KSK): A Retrospective Cross-sectional Case Series from Tirupati
Current Traditional Medicine A Further Step Toward an Optimal Ensemble of Classifiers for Peptide Classification, a Case Study: HIV Protease
Protein & Peptide Letters Repositioning of Drugs as a Promising Strategy to Fight COVID-19
Coronaviruses Covid-19: An Update on Clinical Features, Diagnosis, and Treatment Strategies
Coronaviruses Visual and Quantitative Assessment of COVID-19 Pneumonia on Chest CT: The Relationship with Disease Severity and Clinical Findings
Current Medical Imaging Impacts of Bioinformatics to Medicinal Chemistry
Medicinal Chemistry Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
Current Drug Targets Emerging Evidence for Neuropsycho-Consequences of COVID-19
Current Neuropharmacology Quantification of Glycyrrhetic Acid in Human Plasma by LC–MS/MS: Application to a Pharmacokinetic Study
Current Pharmaceutical Analysis Clinical Spectrum, Geographical Variability of COVID-19, and its Implications
Coronaviruses Effectiveness of a Lockdown Policy During a Global Pandemic
Current Chinese Science Recent Advances Towards Drug Design Targeting the Protease of 2019 Novel Coronavirus (2019-nCoV)
Current Medicinal Chemistry